<DOC>
	<DOCNO>NCT02669589</DOCNO>
	<brief_summary>The aim study evaluate effect regional citrate anticoagulation within scope continuous renal replacement ( CRRT ) critically ill patient acute kidney injury ( AKI ) filter life span 90-day cause mortality .</brief_summary>
	<brief_title>Investigating Different Anticoagulants Renal Replacement Therapy</brief_title>
	<detailed_description>Purpose clinical trial : To evaluate effect regional citrate anticoagulation within scope continuous renal replacement ( CRRT ) critically ill patient acute kidney injury ( AKI ) filter life span 90-day cause mortality . Patient population : critically ill patient acute kidney injury require renal replacement therapy . Primary objective : Anticoagulation extracorporeal circuit require continuous RRT ( CRRT ) . To date , clear anticoagulant use CRRT . Regional citrate anticoagulation ( RCA ) CRRT critically ill patient AKI prolongs filter life span reduce 90-day cause mortality approximately 8 % ( 48 % 40 % ) compare systemic heparin anticoagulation CRRT</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . Critically ill patient clinical indication CRRT ( clinical decision use continuous RRT due hemodynamic instability ) Or Severe acute kidney injury ( KDIGO 3classification ) despite optimal resuscitation 2 . At least one follow condition Severe sepsis septic shock Use catecholamine ( norepinephrine epinephrine ≥ 0.1 µg/kg/min norepinephrine ≥ 0.05 µg/kg/min + dobutamine ( dose ) norepinephrine ≥ 0.05 µg/kg/min + vasopressin ( dose ) epinephrine ≥ 0.05 µg/kg/min + norepinephrine ≥ 0.05 µg/kg/min ) Refractory fluid overload : worsening pulmonary edema : PaO2/FiO2 &lt; 300 mmHg and/or fluid balance &gt; 10 % body weight ) 3 . 1890 year old 4 . Intention provide full intensive care treatment least 3 day 5 . Written informed consent patient legal representative authorize representative inclusion due emergency situation 1 . Patients increase bleed risk ( e.g . active bleeding ulcer gastrointestinal tract , hypertension diastolic blood pressure high 105 mm Hg , injury ( intracranial hemorrhage , aneurysm brain artery ) surgical procedure central nervous system heparinization target aPTT 4560 allow treat neurologist neurosurgeon , severe retinopathy , bleed vitreum , ophthalmic surgical procedure ) ) injury , active tuberculosis ; infective endocarditis ) 2 . Disease organ damage relate hemorrhagic diathesis ( coagulopathy , thrombocytopenia , severe liver pancreas disease ) 3 . Preexisting kidney disease KDOQI IV require RRT ( GFR &lt; 30 mL/min ) 4 . Previous renalreplacement therapy due acute kidney injury last 90 day 5 . Dialysisdependent chronic kidney insufficiency 6 . Need therapeutic systemic anticoagulation 7 . Allergic reaction one anticoagulants ingredient , Heparininduced thrombocytopenia 8 . AKI cause permanent occlusion surgical lesion renal artery 9 . AKI cause ( glomerulo ) nephritis , interstitial nephritis , vasculitis postrenal obstruction 10 . Donotresuscitate order 11 . Hemolyticuremic syndrome/thrombotic thrombocytopenic purpura 12 . Persistent severe lactate acidosis context acute liver failure and/or shock 13 . Kidney transplant within last 12 month 14 . Pregnancy nurse period 15 . Abortus imminens 16 . No hemofiltration machine free use moment inclusion 17 . Participation another clinical intervention trial last 3 month 18 . Persons kind dependency investigator employ sponsor investigator 19 . Persons hold institution legal official order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>CRRT</keyword>
	<keyword>AKI</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>KDIGO</keyword>
</DOC>